Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Medullomyoblastoma: a histological, immunohistochemical, ultrastructural and molecular genetic study.

Bergmann M, Pietsch T, Herms J, Janus J, Spaar HJ, Terwey B.

Acta Neuropathol. 1998 Feb;95(2):205-12.

PMID:
9498058
2.

Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.

Lindberg E, Persson A, Øra I, Mertens F, Englund E, Gisselsson D.

Neuropathology. 2007 Dec;27(6):556-60.

PMID:
18021376
3.
4.

Medullomyoblastoma with calcification: a case report.

Chaturvedi S, Gupta S, Singhal S, Kumari R.

Neuropathology. 2008 Feb;28(1):93-7. doi: 10.1111/j.1440-1789.2007.00833.x.

PMID:
18181837
5.

[A case of medullomyoblastoma].

Aramaki Y, Shimokawa S, Nakashima S, Nakamura Y.

No Shinkei Geka. 2011 Nov;39(11):1073-7. Review. Japanese.

PMID:
22036819
6.

Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

Schofield D, West DC, Anthony DC, Marshal R, Sklar J.

Am J Pathol. 1995 Feb;146(2):472-80.

7.

Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.

Albrecht S, von Deimling A, Pietsch T, Giangaspero F, Brandner S, Kleihues P, Wiestler OD.

Neuropathol Appl Neurobiol. 1994 Feb;20(1):74-81.

PMID:
8208343
8.
9.

Tumor suppressor genes and medulloblastoma.

Cogen PH, McDonald JD.

J Neurooncol. 1996 Jul;29(1):103-12. Review.

PMID:
8817421
10.

Medullomyoblastoma in an adult.

Rao C, Friedlander ME, Klein E, Anzil AP, Sher JH.

Cancer. 1990 Jan 1;65(1):157-63.

11.

Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.

Polydorides AD, Perry A, Edgar MA.

J Neurooncol. 2008 Jun;88(2):193-7. doi: 10.1007/s11060-008-9548-y.

PMID:
18317693
12.

[Medullomyoblastoma: immunohistochemical and ultrastructural study].

Labrousse F, Lhermine A, Maunoury R, Daumas-Duport C, Vedrenne C.

Arch Anat Cytol Pathol. 1990;38(5-6):198-202. French.

PMID:
2281954
13.

Cytogenetic abnormalities in a disseminated medulloblastoma.

Stuart AG, Pearson AD, Emslie J, Lennard A, Davison EV, Perry RH, Crawford PJ.

Med Pediatr Oncol. 1993;21(4):295-8.

PMID:
8469226
14.

Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.

Biegel JA, Janss AJ, Raffel C, Sutton L, Rorke LB, Harper JM, Phillips PC.

Clin Cancer Res. 1997 Mar;3(3):473-8.

15.

Medullomyoblastoma: a case report.

Lai CR, Ho DM, Liu HC.

Zhonghua Yi Xue Za Zhi (Taipei). 1989 Jul;44(1):65-70.

PMID:
2819571
16.

Medulloblastoma demonstrating multipotent differentiation: case report.

Sakata H, Kanamori M, Watanabe M, Kumabe T, Tominaga T.

Brain Tumor Pathol. 2008;25(1):39-43. doi: 10.1007/s10014-007-0228-y. Epub 2008 Apr 16.

PMID:
18415665
17.

Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.

Emadian SM, McDonald JD, Gerken SC, Fults D.

Clin Cancer Res. 1996 Sep;2(9):1559-64.

19.

Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.

Leonard JR, Cai DX, Rivet DJ, Kaufman BA, Park TS, Levy BK, Perry A.

J Neurosurg. 2001 Jul;95(1):82-8.

PMID:
11453402
20.

Prognostic implications of chromosome 17p deletions in human medulloblastomas.

Batra SK, McLendon RE, Koo JS, Castelino-Prabhu S, Fuchs HE, Krischer JP, Friedman HS, Bigner DD, Bigner SH.

J Neurooncol. 1995;24(1):39-45.

PMID:
8523074

Supplemental Content

Support Center